MEDX.SW Stock Analysis
ME
Uncovered
medmix AG is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
medmix AG engages in the business of design and production of delivery devices and applicators for the dental, drug delivery, surgery, industrial, and beauty markets. The company is headquartered in Baar, Zug and currently employs 2,067 full-time employees. The company went IPO on 2021-09-30. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.